Top Markets
Coin of the day
Kadimastem Ltd Kadimastem Ltd

Kadimastem Ltd

KDST
Rang in Aktien #41019
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
Aktienkurs
$12.16
Zuletzt synchronisiert: 2025-10-30
Marktkapitalisierung
$50.98K
Veränderung (1 Tag)
-0.10%
Veränderung (1 Jahr)
56.95%
Land
IL
Handel Kadimastem Ltd (KDST)

Kategorie

Kursverlauf für Kadimastem Ltd (KDST)
Höchster Schlusskurs: $9.90 am 2025-10-01

Niedrigster Schlusskurs: $113.98 am 2013-06-01
Kursverlauf der Aktie von Kadimastem Ltd von 2013 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -10.38%
2025 197.20%
2024 108.39%
2023 -54.57%
2022 -69.58%
2021 53.27%
2020 -46.58%
2019 -34.74%
2018 60.03%
2017 -90.10%
2016 -11.16%
2015 130.17%
2014 -4.24%
2013 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$522.59 31.99%
US
$863.65 33.57%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE